
- 1D
- 1W
- 1M
- 1Y
- 5Y
- YTD
About Rain Therapeutics
Rain Therapeutics Inc. operates as a clinical stage biotechnology company. The Company develops and produces biomarker-driven small molecule therapeutics for patients with cancer and other related diseases. Rain Therapeutics serves customers worldwide.
Stock Analysis

last close
$2.28
1-mo return
-44.8%
3-mo return
-63.9%
avg daily vol.
65.28T
52-week high
22.22
52-week low
2.2
market cap.
$50M
forward pe
-
annual div.
-
roe
-176.9%
ltg forecast
-
dividend yield
-
annual rev.
$--
inst own.
83.6%